IL281660A - A high-affinity T-cell receptor for AFP antigen recognition - Google Patents
A high-affinity T-cell receptor for AFP antigen recognitionInfo
- Publication number
- IL281660A IL281660A IL281660A IL28166021A IL281660A IL 281660 A IL281660 A IL 281660A IL 281660 A IL281660 A IL 281660A IL 28166021 A IL28166021 A IL 28166021A IL 281660 A IL281660 A IL 281660A
- Authority
- IL
- Israel
- Prior art keywords
- high affinity
- cell receptor
- afp antigen
- recognizing
- recognizing afp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811109677 | 2018-09-21 | ||
| PCT/CN2019/106816 WO2020057619A1 (zh) | 2018-09-21 | 2019-09-19 | 一种识别afp抗原的高亲和力t细胞受体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL281660A true IL281660A (en) | 2021-05-31 |
Family
ID=69888304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL281660A IL281660A (en) | 2018-09-21 | 2021-03-21 | A high-affinity T-cell receptor for AFP antigen recognition |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12275773B2 (https=) |
| EP (1) | EP3854802A4 (https=) |
| JP (1) | JP7505785B2 (https=) |
| KR (1) | KR20210108941A (https=) |
| CN (1) | CN110938136B (https=) |
| AU (1) | AU2019344871B2 (https=) |
| CA (1) | CA3113536A1 (https=) |
| IL (1) | IL281660A (https=) |
| SG (1) | SG11202102903QA (https=) |
| WO (1) | WO2020057619A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113621070A (zh) | 2020-05-06 | 2021-11-09 | 华夏英泰(北京)生物技术有限公司 | 一种t细胞抗原受体、其多聚体复合物及其制备方法和应用 |
| CN113667008A (zh) * | 2020-05-15 | 2021-11-19 | 香雪生命科学技术(广东)有限公司 | 一种识别afp抗原的高亲和力t细胞受体 |
| CN119930796B (zh) * | 2025-04-10 | 2025-09-16 | 恒瑞源正(广州)生物科技有限公司 | 一种t细胞受体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2645256C2 (ru) | 2013-06-26 | 2018-02-19 | Гуандун Сянсюэ Лайф Сайенсис, Лтд. | Высокостабильный т-клеточный рецептор и способ его получения и применения |
| GB201313377D0 (en) * | 2013-07-26 | 2013-09-11 | Adaptimmune Ltd | T cell receptors |
| CN104087592B (zh) * | 2014-05-13 | 2016-01-27 | 天津医科大学总医院 | Afp158-166特异性tcr基因及其转基因t细胞及体外增殖方法及用途 |
| AU2016243026B2 (en) * | 2015-04-03 | 2022-03-31 | Eureka Therapeutics, Inc. | Constructs targeting AFP peptide/MHC complexes and uses thereof |
| CN106459178B (zh) * | 2015-09-09 | 2018-06-12 | 广东香雪精准医疗技术有限公司 | 针对rhamm抗原短肽的高亲和力t细胞受体 |
| CN106519019B (zh) * | 2015-11-06 | 2018-07-03 | 广东香雪精准医疗技术有限公司 | 识别prame抗原的tcr |
| GB201604494D0 (en) | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers |
| GB201608052D0 (en) * | 2016-05-09 | 2016-06-22 | Univ Oslo Hf | T-cell receptors which recognise frameshift mutants of TGF-beta RII |
| CN108264550B (zh) * | 2017-01-04 | 2021-04-23 | 香雪生命科学技术(广东)有限公司 | 一种识别源自于prame抗原短肽的tcr |
| CN109575121B (zh) * | 2017-09-28 | 2022-09-09 | 香雪生命科学技术(广东)有限公司 | 识别afp抗原短肽的t细胞受体 |
-
2019
- 2019-09-19 CA CA3113536A patent/CA3113536A1/en active Pending
- 2019-09-19 JP JP2021540357A patent/JP7505785B2/ja active Active
- 2019-09-19 US US17/278,504 patent/US12275773B2/en active Active
- 2019-09-19 AU AU2019344871A patent/AU2019344871B2/en active Active
- 2019-09-19 KR KR1020217011808A patent/KR20210108941A/ko active Pending
- 2019-09-19 EP EP19861880.3A patent/EP3854802A4/en active Pending
- 2019-09-19 SG SG11202102903QA patent/SG11202102903QA/en unknown
- 2019-09-19 WO PCT/CN2019/106816 patent/WO2020057619A1/zh not_active Ceased
- 2019-09-19 CN CN201910888722.8A patent/CN110938136B/zh active Active
-
2021
- 2021-03-21 IL IL281660A patent/IL281660A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US12275773B2 (en) | 2025-04-15 |
| CN110938136A (zh) | 2020-03-31 |
| KR20210108941A (ko) | 2021-09-03 |
| EP3854802A4 (en) | 2022-10-12 |
| WO2020057619A1 (zh) | 2020-03-26 |
| JP7505785B2 (ja) | 2024-06-25 |
| JP2022502078A (ja) | 2022-01-11 |
| AU2019344871B2 (en) | 2025-04-03 |
| AU2019344871A1 (en) | 2021-05-20 |
| US20220033458A1 (en) | 2022-02-03 |
| SG11202102903QA (en) | 2021-04-29 |
| AU2019344871A2 (en) | 2021-06-17 |
| CN110938136B (zh) | 2022-09-09 |
| EP3854802A1 (en) | 2021-07-28 |
| CA3113536A1 (en) | 2020-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280780A (en) | Anti-TIGIT antibodies | |
| ZA202101537B (en) | Anti-trem-2 agonist antibodies | |
| IL276746A (en) | Kir3dl3 as hhla2 receptor, anti-hhla2 antibodies and their uses | |
| IL280013A (en) | Anti-IL36R antibodies | |
| IL276397A (en) | Antibodies specific to CD70 and their uses | |
| IL279352A (en) | IL-11RA antibodies | |
| SG11201708061TA (en) | Antibodies directed against interleukin 36 receptor (il-36r) | |
| SG10202107165XA (en) | Anti-transferrin receptor antibodies with tailored affinity | |
| SG11202000606TA (en) | Reagents for expanding cells expressing recombinant receptors | |
| MX376026B (es) | Inmunoreceptores especificos de claudina-6 y epitopos de celulas t. | |
| EP3831845A4 (en) | T-LYMPHOCYTE RECEPTOR TO IDENTIFY AN AFP ANTIGEN | |
| IL278010A (en) | Antibodies to galectin 10 | |
| GB202110263D0 (en) | Anti-btla antibodies | |
| IL277946A (en) | Chimeric antigen receptors for the interleukin-23 receptor | |
| IL277030A (en) | Antibodies | |
| GB2551945B (en) | Novel GLP-1 receptor agonist peptides | |
| IL281660A (en) | A high-affinity T-cell receptor for AFP antigen recognition | |
| SG11202102114UA (en) | Anti-klrg1 antibodies | |
| GB201806084D0 (en) | Antibodies | |
| IL277510A (en) | Anti-137CD antibodies for combination with anti-L1-PD antibodies | |
| GB201817676D0 (en) | T cell antigen receptor chimera | |
| GB201721831D0 (en) | T cell antigen receptor chimera | |
| SG11202105718TA (en) | Modified antibodies | |
| GB201917059D0 (en) | Hybrid antibody | |
| GB201914165D0 (en) | Hybrid antibody |